Amerisourcebergen Corp
NYSE:ABC
Intrinsic Value
The intrinsic value of one
ABC
stock under the Base Case scenario is
354.99
USD.
Compared to the current market price of 155.08 USD,
Amerisourcebergen Corp
is
Undervalued by 56%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
ABC Profitability Score
Profitability Due Diligence
Amerisourcebergen Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Amerisourcebergen Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
ABC Solvency Score
Solvency Due Diligence
Amerisourcebergen Corp's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Amerisourcebergen Corp's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Amerisourcebergen Corp
ABC Capital Structure
Amerisourcebergen Corp
| Market Capitalization | 32B USD | |
| Total Debt | 4.6B USD | |
| Minority Interest | 283M USD | |
| Preferred Equity | 0 USD | |
| Cash and Equivalents | 3.4B USD | |
| Short-Term Investments | 0 USD | |
| Enterprise Value | 33.5B USD | |
Wall St
Price Targets
ABC Price Targets Summary
Amerisourcebergen Corp
According to Wall Street analysts, the average 1-year price target for
ABC
is 183.86 USD
with a low forecast of 156.55 USD and a high forecast of 208.95 USD.
Competitive Landscape
ABC Competitors
Amerisourcebergen Corp
ABC Suppliers & Customers
Amerisourcebergen Corp
Amerisourcebergen Corp has 54 key suppliers from 7 countries and 5 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Pharmaceuticals industry.
Amerisourcebergen Corp has 8 key customers from 4 countries and 4 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Biotechnology industry.
Ownership
ABC Insider Trading
Buy and sell transactions by insiders
During the last 12 months Amerisourcebergen Corp insiders have not bought any shares, and sold 4B USD worth of shares. The last transaction was made on Feb 6, 2023 by Collis Steven H (Chairman, President & CEO), who sold 1.7M USD worth of ABC shares.
Shareholder Return
ABC Price
Amerisourcebergen Corp
| Average Annual Return | 13.55% |
| Standard Deviation of Annual Returns | 23.36% |
| Max Drawdown | -29% |
| Market Capitalization | 32B USD |
| Shares Outstanding | 202 440 992 |
| Percentage of Shares Shorted | 4.02% |
Company Profile
Amerisourcebergen Corp
Country
Industry
Market Cap
Dividend Yield
Description
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. The company is headquartered in Conshohocken, Pennsylvania and currently employs 38,000 full-time employees. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty.
Contact
IPO
Employees
Officers
The intrinsic value of one
ABC
stock under the Base Case scenario is
354.99
USD.
Compared to the current market price of 155.08 USD, Amerisourcebergen Corp is Undervalued by 56%.
